Expression of inflammatory mediators in biofilm samples and clinical association in inflammatory bowel disease patients—a preliminary study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Clinical Oral Investigations 26.2 (2022): S. 1217-1228.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2022
- Urheber
-
Buchbender, Mayte
Fehlhofer, Jakob
Proff, Peter
Möst, Tobias
Ries, Jutta
Hannig, Matthias
Neurath, Markus F.
Gund, Madline
Atreya, Raja
Kesting, Marco
- DOI
-
10.1007/s00784-021-04093-2
- URN
-
urn:nbn:de:bvb:29-opus4-221454
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Buchbender, Mayte
- Fehlhofer, Jakob
- Proff, Peter
- Möst, Tobias
- Ries, Jutta
- Hannig, Matthias
- Neurath, Markus F.
- Gund, Madline
- Atreya, Raja
- Kesting, Marco
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2022
Ähnliche Objekte (12)
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases
Endoscopic Therapy in Inflammatory Bowel Diseases
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Role of the IL23/IL17 Pathway in Crohn’s Disease
Experimentelle Untersuchungen zur Frage der Abriebfestigkeit des exogenen Zahnoberhäutchens
Quantitative contrast-enhanced ultrasound for monitoring vedolizumab therapy in inflammatory bowel disease patients: a pilot study
Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy
Molecular Endoscopy and in vivo Imaging in Inflammatory Bowel Diseases
Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Inflammatory Bowel Diseases: Current Medical and Surgical Therapy
Mucosal healing in inflammatory bowel diseases: a systematic review
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases
Endoscopic Therapy in Inflammatory Bowel Diseases
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Role of the IL23/IL17 Pathway in Crohn’s Disease
Experimentelle Untersuchungen zur Frage der Abriebfestigkeit des exogenen Zahnoberhäutchens
Quantitative contrast-enhanced ultrasound for monitoring vedolizumab therapy in inflammatory bowel disease patients: a pilot study
Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy
Molecular Endoscopy and in vivo Imaging in Inflammatory Bowel Diseases
Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Inflammatory Bowel Diseases: Current Medical and Surgical Therapy
Mucosal healing in inflammatory bowel diseases: a systematic review
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases
Endoscopic Therapy in Inflammatory Bowel Diseases
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Role of the IL23/IL17 Pathway in Crohn’s Disease
Experimentelle Untersuchungen zur Frage der Abriebfestigkeit des exogenen Zahnoberhäutchens
Quantitative contrast-enhanced ultrasound for monitoring vedolizumab therapy in inflammatory bowel disease patients: a pilot study
Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy
Molecular Endoscopy and in vivo Imaging in Inflammatory Bowel Diseases
Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Inflammatory Bowel Diseases: Current Medical and Surgical Therapy